SSL Secure
Tirzepatide 2.5mg - Metabolic Health product image 1 of 1 - Prost Biotech
Metabolic Health

Tirzepatide 2.5mg

≥99% PurityHPLC + MS VerifiedCOA Included3rd-Party TestedIn Stock

Tirzepatide 2.5mg starting-dose research vial — entry-level dual GIP/GLP-1 receptor agonist for pilot studies and dose-titration protocols.

Bulk / Wholesale Inquiry

10+ vials · OEM / Private Label · Cold-chain Export Shipping

Get Factory Quote on WhatsApp

Volume Pricing

1 vial
Standard
5+ vials
Save 15%
10+ vials
Save 30%
OEM / Bulk
Factory Quote

Discounts applied via WhatsApp quote for qualified research / clinic inquiries.

Tirzepatide 2.5mg is the standard initiation dose for incretin pathway research. Supplied as lyophilized powder for reconstitution, this vial is intended for in-vitro research and qualified clinic protocols where lower-concentration delivery is preferred — including dose-escalation studies, tolerability baselines, and pilot metabolic investigations.

Key Benefits

  • Standard initiation dose for tirzepatide research protocols
  • ≥99% HPLC-verified purity, lyophilized powder format
  • Dual GIP/GLP-1 receptor agonist mechanism
  • Compatible with bacteriostatic-water reconstitution
  • Batch-matched Certificate of Analysis (COA)
  • Suitable for dose-titration and pilot study protocols

Scientific Background

The 2.5mg dose mirrors the standard clinical-trial initiation concentration, providing a measurable baseline for incretin-receptor stimulation studies. Research teams use this strength to calibrate dose-response curves and document tolerability metrics before escalating to higher therapeutic ranges.

View Reference Guide

Educational Display Only
This product information is for educational purposes. Always consult licensed healthcare providers for personalized medical advice.

Frequently Asked Questions